nodes	percent_of_prediction	percent_of_DWPC	metapath
Rifabutin—CYP1A2—type 2 diabetes mellitus	0.23	0.602	CbGaD
Rifabutin—CYP3A4—type 2 diabetes mellitus	0.152	0.398	CbGaD
Rifabutin—CYP1A2—Rosiglitazone—type 2 diabetes mellitus	0.0345	0.113	CbGbCtD
Rifabutin—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.0304	0.0999	CbGbCtD
Rifabutin—CYP1A2—Irbesartan—type 2 diabetes mellitus	0.0272	0.0893	CbGbCtD
Rifabutin—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.0271	0.089	CbGbCtD
Rifabutin—CYP1A2—Bromocriptine—type 2 diabetes mellitus	0.0257	0.0844	CbGbCtD
Rifabutin—CYP3A4—Glipizide—type 2 diabetes mellitus	0.0248	0.0814	CbGbCtD
Rifabutin—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.0217	0.0712	CbGbCtD
Rifabutin—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.0196	0.0644	CbGbCtD
Rifabutin—CYP1A2—Losartan—type 2 diabetes mellitus	0.0175	0.0575	CbGbCtD
Rifabutin—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.0149	0.0488	CbGbCtD
Rifabutin—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.0142	0.0468	CbGbCtD
Rifabutin—CYP3A4—Orlistat—type 2 diabetes mellitus	0.0142	0.0468	CbGbCtD
Rifabutin—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.0135	0.0442	CbGbCtD
Rifabutin—CYP3A4—Glyburide—type 2 diabetes mellitus	0.01	0.0329	CbGbCtD
Rifabutin—CYP3A4—Losartan—type 2 diabetes mellitus	0.00918	0.0301	CbGbCtD
Rifabutin—HSP90AA1—endothelium—type 2 diabetes mellitus	0.00437	0.0992	CbGeAlD
Rifabutin—HSP90B1—islet of Langerhans—type 2 diabetes mellitus	0.0034	0.0772	CbGeAlD
Rifabutin—HSP90B1—retina—type 2 diabetes mellitus	0.00291	0.066	CbGeAlD
Rifabutin—HSP90B1—nephron tubule—type 2 diabetes mellitus	0.00274	0.0621	CbGeAlD
Rifabutin—HSP90AA1—islet of Langerhans—type 2 diabetes mellitus	0.00249	0.0564	CbGeAlD
Rifabutin—HSP90B1—cardiovascular system—type 2 diabetes mellitus	0.00246	0.0558	CbGeAlD
Rifabutin—HSP90B1—kidney—type 2 diabetes mellitus	0.00241	0.0546	CbGeAlD
Rifabutin—HSP90B1—pancreas—type 2 diabetes mellitus	0.00239	0.0542	CbGeAlD
Rifabutin—HSP90B1—cortex of kidney—type 2 diabetes mellitus	0.00234	0.0532	CbGeAlD
Rifabutin—HSP90B1—adipose tissue—type 2 diabetes mellitus	0.00217	0.0492	CbGeAlD
Rifabutin—HSP90AA1—retina—type 2 diabetes mellitus	0.00213	0.0482	CbGeAlD
Rifabutin—HSP90AA1—nephron tubule—type 2 diabetes mellitus	0.002	0.0454	CbGeAlD
Rifabutin—HSP90AA1—cardiovascular system—type 2 diabetes mellitus	0.0018	0.0408	CbGeAlD
Rifabutin—HSP90AA1—kidney—type 2 diabetes mellitus	0.00176	0.0399	CbGeAlD
Rifabutin—HSP90AA1—pancreas—type 2 diabetes mellitus	0.00175	0.0397	CbGeAlD
Rifabutin—HSP90AA1—cortex of kidney—type 2 diabetes mellitus	0.00171	0.0389	CbGeAlD
Rifabutin—HSP90AA1—adipose tissue—type 2 diabetes mellitus	0.00159	0.036	CbGeAlD
Rifabutin—HSP90B1—liver—type 2 diabetes mellitus	0.00152	0.0345	CbGeAlD
Rifabutin—HSP90AA1—liver—type 2 diabetes mellitus	0.00111	0.0252	CbGeAlD
Rifabutin—Rifaximin—CYP3A4—type 2 diabetes mellitus	0.000768	0.259	CrCbGaD
Rifabutin—Rifampicin—ABCC2—type 2 diabetes mellitus	0.000623	0.21	CrCbGaD
Rifabutin—Rifapentine—CYP3A4—type 2 diabetes mellitus	0.000441	0.149	CrCbGaD
Rifabutin—Rifampicin—CYP2E1—type 2 diabetes mellitus	0.000437	0.148	CrCbGaD
Rifabutin—Rifampicin—CYP1A2—type 2 diabetes mellitus	0.000416	0.14	CrCbGaD
Rifabutin—CYP3A4—kidney—type 2 diabetes mellitus	0.000412	0.00934	CbGeAlD
Rifabutin—CYP1A2—liver—type 2 diabetes mellitus	0.00036	0.00816	CbGeAlD
Rifabutin—Rifampicin—CYP3A4—type 2 diabetes mellitus	0.000275	0.093	CrCbGaD
Rifabutin—CYP3A4—liver—type 2 diabetes mellitus	0.00026	0.00591	CbGeAlD
Rifabutin—Hypersensitivity—Glimepiride—type 2 diabetes mellitus	0.000185	0.00124	CcSEcCtD
Rifabutin—Asthenia—Pioglitazone—type 2 diabetes mellitus	0.000185	0.00124	CcSEcCtD
Rifabutin—Dyspnoea—Glyburide—type 2 diabetes mellitus	0.000184	0.00123	CcSEcCtD
Rifabutin—Hypersensitivity—Sitagliptin—type 2 diabetes mellitus	0.000184	0.00123	CcSEcCtD
Rifabutin—Diarrhoea—Glipizide—type 2 diabetes mellitus	0.000184	0.00123	CcSEcCtD
Rifabutin—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.000182	0.00122	CcSEcCtD
Rifabutin—Dyspepsia—Glyburide—type 2 diabetes mellitus	0.000182	0.00122	CcSEcCtD
Rifabutin—Thrombocytopenia—Gliclazide—type 2 diabetes mellitus	0.000182	0.00122	CcSEcCtD
Rifabutin—Jaundice—Ramipril—type 2 diabetes mellitus	0.000181	0.00121	CcSEcCtD
Rifabutin—Skin disorder—Gliclazide—type 2 diabetes mellitus	0.00018	0.00121	CcSEcCtD
Rifabutin—Asthenia—Glimepiride—type 2 diabetes mellitus	0.00018	0.0012	CcSEcCtD
Rifabutin—Decreased appetite—Glyburide—type 2 diabetes mellitus	0.00018	0.0012	CcSEcCtD
Rifabutin—Asthenia—Sitagliptin—type 2 diabetes mellitus	0.000179	0.0012	CcSEcCtD
Rifabutin—Convulsion—Orlistat—type 2 diabetes mellitus	0.000179	0.0012	CcSEcCtD
Rifabutin—Abdominal pain—Bromocriptine—type 2 diabetes mellitus	0.000179	0.0012	CcSEcCtD
Rifabutin—Body temperature increased—Bromocriptine—type 2 diabetes mellitus	0.000179	0.0012	CcSEcCtD
Rifabutin—Gastrointestinal disorder—Glyburide—type 2 diabetes mellitus	0.000178	0.0012	CcSEcCtD
Rifabutin—Arthralgia—Valsartan—type 2 diabetes mellitus	0.000178	0.00119	CcSEcCtD
Rifabutin—Chest pain—Valsartan—type 2 diabetes mellitus	0.000178	0.00119	CcSEcCtD
Rifabutin—Myalgia—Valsartan—type 2 diabetes mellitus	0.000178	0.00119	CcSEcCtD
Rifabutin—Pruritus—Glimepiride—type 2 diabetes mellitus	0.000177	0.00119	CcSEcCtD
Rifabutin—Flatulence—Irbesartan—type 2 diabetes mellitus	0.000177	0.00119	CcSEcCtD
Rifabutin—Unspecified disorder of skin and subcutaneous tissue—Valsartan—type 2 diabetes mellitus	0.000177	0.00118	CcSEcCtD
Rifabutin—Diarrhoea—Pioglitazone—type 2 diabetes mellitus	0.000176	0.00118	CcSEcCtD
Rifabutin—Dysgeusia—Irbesartan—type 2 diabetes mellitus	0.000176	0.00118	CcSEcCtD
Rifabutin—Chest pain—Orlistat—type 2 diabetes mellitus	0.000176	0.00118	CcSEcCtD
Rifabutin—Myalgia—Orlistat—type 2 diabetes mellitus	0.000176	0.00118	CcSEcCtD
Rifabutin—Hepatobiliary disease—Ramipril—type 2 diabetes mellitus	0.000175	0.00118	CcSEcCtD
Rifabutin—Unspecified disorder of skin and subcutaneous tissue—Orlistat—type 2 diabetes mellitus	0.000175	0.00117	CcSEcCtD
Rifabutin—Agranulocytosis—Ramipril—type 2 diabetes mellitus	0.000173	0.00116	CcSEcCtD
Rifabutin—Diarrhoea—Glimepiride—type 2 diabetes mellitus	0.000171	0.00115	CcSEcCtD
Rifabutin—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	0.000171	0.00115	CcSEcCtD
Rifabutin—Vomiting—Glipizide—type 2 diabetes mellitus	0.000171	0.00114	CcSEcCtD
Rifabutin—Feeling abnormal—Glyburide—type 2 diabetes mellitus	0.00017	0.00114	CcSEcCtD
Rifabutin—Rash—Glipizide—type 2 diabetes mellitus	0.000169	0.00113	CcSEcCtD
Rifabutin—Dermatitis—Glipizide—type 2 diabetes mellitus	0.000169	0.00113	CcSEcCtD
Rifabutin—Musculoskeletal discomfort—Gliclazide—type 2 diabetes mellitus	0.000169	0.00113	CcSEcCtD
Rifabutin—Gastrointestinal pain—Glyburide—type 2 diabetes mellitus	0.000169	0.00113	CcSEcCtD
Rifabutin—Headache—Glipizide—type 2 diabetes mellitus	0.000168	0.00113	CcSEcCtD
Rifabutin—Insomnia—Gliclazide—type 2 diabetes mellitus	0.000168	0.00112	CcSEcCtD
Rifabutin—Shock—Valsartan—type 2 diabetes mellitus	0.000168	0.00112	CcSEcCtD
Rifabutin—Thrombocytopenia—Valsartan—type 2 diabetes mellitus	0.000167	0.00112	CcSEcCtD
Rifabutin—Paraesthesia—Gliclazide—type 2 diabetes mellitus	0.000167	0.00112	CcSEcCtD
Rifabutin—Flatulence—Losartan—type 2 diabetes mellitus	0.000166	0.00112	CcSEcCtD
Rifabutin—Hepatitis—Ramipril—type 2 diabetes mellitus	0.000166	0.00112	CcSEcCtD
Rifabutin—Anaemia—Irbesartan—type 2 diabetes mellitus	0.000166	0.00111	CcSEcCtD
Rifabutin—Skin disorder—Valsartan—type 2 diabetes mellitus	0.000166	0.00111	CcSEcCtD
Rifabutin—Dysgeusia—Losartan—type 2 diabetes mellitus	0.000165	0.00111	CcSEcCtD
Rifabutin—Dyspnoea—Gliclazide—type 2 diabetes mellitus	0.000165	0.00111	CcSEcCtD
Rifabutin—Skin disorder—Orlistat—type 2 diabetes mellitus	0.000164	0.0011	CcSEcCtD
Rifabutin—Connective tissue disorder—Ramipril—type 2 diabetes mellitus	0.000164	0.0011	CcSEcCtD
Rifabutin—Abdominal pain—Glyburide—type 2 diabetes mellitus	0.000163	0.00109	CcSEcCtD
Rifabutin—Dyspepsia—Gliclazide—type 2 diabetes mellitus	0.000163	0.00109	CcSEcCtD
Rifabutin—Anorexia—Valsartan—type 2 diabetes mellitus	0.000162	0.00109	CcSEcCtD
Rifabutin—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.000162	0.00109	CcSEcCtD
Rifabutin—Myalgia—Metformin—type 2 diabetes mellitus	0.000162	0.00109	CcSEcCtD
Rifabutin—Chest pain—Metformin—type 2 diabetes mellitus	0.000162	0.00109	CcSEcCtD
Rifabutin—Headache—Pioglitazone—type 2 diabetes mellitus	0.000161	0.00108	CcSEcCtD
Rifabutin—Unspecified disorder of skin and subcutaneous tissue—Metformin—type 2 diabetes mellitus	0.000161	0.00108	CcSEcCtD
Rifabutin—Leukopenia—Irbesartan—type 2 diabetes mellitus	0.000161	0.00108	CcSEcCtD
Rifabutin—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	0.00016	0.00107	CcSEcCtD
Rifabutin—Nausea—Glipizide—type 2 diabetes mellitus	0.000159	0.00107	CcSEcCtD
Rifabutin—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000159	0.00107	CcSEcCtD
Rifabutin—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000159	0.00106	CcSEcCtD
Rifabutin—Pain—Gliclazide—type 2 diabetes mellitus	0.000159	0.00106	CcSEcCtD
Rifabutin—Rash—Glimepiride—type 2 diabetes mellitus	0.000158	0.00106	CcSEcCtD
Rifabutin—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000158	0.00106	CcSEcCtD
Rifabutin—Rash—Sitagliptin—type 2 diabetes mellitus	0.000157	0.00106	CcSEcCtD
Rifabutin—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000157	0.00105	CcSEcCtD
Rifabutin—Headache—Glimepiride—type 2 diabetes mellitus	0.000157	0.00105	CcSEcCtD
Rifabutin—Headache—Sitagliptin—type 2 diabetes mellitus	0.000156	0.00105	CcSEcCtD
Rifabutin—Anaemia—Losartan—type 2 diabetes mellitus	0.000156	0.00105	CcSEcCtD
Rifabutin—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	0.000155	0.00104	CcSEcCtD
Rifabutin—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000155	0.00104	CcSEcCtD
Rifabutin—Insomnia—Valsartan—type 2 diabetes mellitus	0.000154	0.00103	CcSEcCtD
Rifabutin—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	0.000153	0.00103	CcSEcCtD
Rifabutin—Paraesthesia—Valsartan—type 2 diabetes mellitus	0.000153	0.00103	CcSEcCtD
Rifabutin—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	0.000153	0.00102	CcSEcCtD
Rifabutin—Chest pain—Irbesartan—type 2 diabetes mellitus	0.000153	0.00102	CcSEcCtD
Rifabutin—Myalgia—Irbesartan—type 2 diabetes mellitus	0.000153	0.00102	CcSEcCtD
Rifabutin—Arthralgia—Irbesartan—type 2 diabetes mellitus	0.000153	0.00102	CcSEcCtD
Rifabutin—Shock—Metformin—type 2 diabetes mellitus	0.000153	0.00102	CcSEcCtD
Rifabutin—Insomnia—Orlistat—type 2 diabetes mellitus	0.000152	0.00102	CcSEcCtD
Rifabutin—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.000152	0.00102	CcSEcCtD
Rifabutin—Thrombocytopenia—Metformin—type 2 diabetes mellitus	0.000152	0.00102	CcSEcCtD
Rifabutin—Dyspnoea—Valsartan—type 2 diabetes mellitus	0.000152	0.00102	CcSEcCtD
Rifabutin—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	0.000152	0.00102	CcSEcCtD
Rifabutin—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	0.000152	0.00102	CcSEcCtD
Rifabutin—Paraesthesia—Orlistat—type 2 diabetes mellitus	0.000151	0.00101	CcSEcCtD
Rifabutin—Leukopenia—Losartan—type 2 diabetes mellitus	0.000151	0.00101	CcSEcCtD
Rifabutin—Skin disorder—Metformin—type 2 diabetes mellitus	0.000151	0.00101	CcSEcCtD
Rifabutin—Immune system disorder—Ramipril—type 2 diabetes mellitus	0.00015	0.00101	CcSEcCtD
Rifabutin—Dyspepsia—Valsartan—type 2 diabetes mellitus	0.00015	0.00101	CcSEcCtD
Rifabutin—Nausea—Glimepiride—type 2 diabetes mellitus	0.000149	0.000998	CcSEcCtD
Rifabutin—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000148	0.000994	CcSEcCtD
Rifabutin—Dyspepsia—Orlistat—type 2 diabetes mellitus	0.000148	0.000994	CcSEcCtD
Rifabutin—Asthenia—Glyburide—type 2 diabetes mellitus	0.000148	0.000994	CcSEcCtD
Rifabutin—Decreased appetite—Valsartan—type 2 diabetes mellitus	0.000148	0.000993	CcSEcCtD
Rifabutin—Anorexia—Metformin—type 2 diabetes mellitus	0.000148	0.000992	CcSEcCtD
Rifabutin—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	0.000147	0.000986	CcSEcCtD
Rifabutin—Abdominal pain—Gliclazide—type 2 diabetes mellitus	0.000147	0.000983	CcSEcCtD
Rifabutin—Body temperature increased—Gliclazide—type 2 diabetes mellitus	0.000147	0.000983	CcSEcCtD
Rifabutin—Decreased appetite—Orlistat—type 2 diabetes mellitus	0.000146	0.000982	CcSEcCtD
Rifabutin—Pruritus—Glyburide—type 2 diabetes mellitus	0.000146	0.00098	CcSEcCtD
Rifabutin—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	0.000145	0.000975	CcSEcCtD
Rifabutin—Shock—Irbesartan—type 2 diabetes mellitus	0.000144	0.000966	CcSEcCtD
Rifabutin—Pain—Orlistat—type 2 diabetes mellitus	0.000144	0.000966	CcSEcCtD
Rifabutin—Chest pain—Losartan—type 2 diabetes mellitus	0.000144	0.000964	CcSEcCtD
Rifabutin—Arthralgia—Losartan—type 2 diabetes mellitus	0.000144	0.000964	CcSEcCtD
Rifabutin—Myalgia—Losartan—type 2 diabetes mellitus	0.000144	0.000964	CcSEcCtD
Rifabutin—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000144	0.000963	CcSEcCtD
Rifabutin—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	0.000143	0.000961	CcSEcCtD
Rifabutin—Rash—Bromocriptine—type 2 diabetes mellitus	0.000143	0.000955	CcSEcCtD
Rifabutin—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000142	0.000954	CcSEcCtD
Rifabutin—Skin disorder—Irbesartan—type 2 diabetes mellitus	0.000142	0.000954	CcSEcCtD
Rifabutin—Dysgeusia—Ramipril—type 2 diabetes mellitus	0.000142	0.000951	CcSEcCtD
Rifabutin—Headache—Bromocriptine—type 2 diabetes mellitus	0.000142	0.000949	CcSEcCtD
Rifabutin—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	0.000141	0.000948	CcSEcCtD
Rifabutin—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000141	0.000948	CcSEcCtD
Rifabutin—Anorexia—Irbesartan—type 2 diabetes mellitus	0.00014	0.000936	CcSEcCtD
Rifabutin—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	0.000139	0.000934	CcSEcCtD
Rifabutin—Paraesthesia—Metformin—type 2 diabetes mellitus	0.000139	0.000934	CcSEcCtD
Rifabutin—Confusional state—Losartan—type 2 diabetes mellitus	0.000139	0.000932	CcSEcCtD
Rifabutin—Feeling abnormal—Orlistat—type 2 diabetes mellitus	0.000139	0.00093	CcSEcCtD
Rifabutin—Dyspnoea—Metformin—type 2 diabetes mellitus	0.000138	0.000928	CcSEcCtD
Rifabutin—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	0.000138	0.000923	CcSEcCtD
Rifabutin—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.000137	0.000916	CcSEcCtD
Rifabutin—Dyspepsia—Metformin—type 2 diabetes mellitus	0.000137	0.000916	CcSEcCtD
Rifabutin—Shock—Losartan—type 2 diabetes mellitus	0.000136	0.000909	CcSEcCtD
Rifabutin—Thrombocytopenia—Losartan—type 2 diabetes mellitus	0.000135	0.000905	CcSEcCtD
Rifabutin—Decreased appetite—Metformin—type 2 diabetes mellitus	0.000135	0.000905	CcSEcCtD
Rifabutin—Abdominal pain—Valsartan—type 2 diabetes mellitus	0.000135	0.000903	CcSEcCtD
Rifabutin—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000134	0.0009	CcSEcCtD
Rifabutin—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	0.000134	0.000898	CcSEcCtD
Rifabutin—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	0.000133	0.000895	CcSEcCtD
Rifabutin—Body temperature increased—Orlistat—type 2 diabetes mellitus	0.000133	0.000893	CcSEcCtD
Rifabutin—Abdominal pain—Orlistat—type 2 diabetes mellitus	0.000133	0.000893	CcSEcCtD
Rifabutin—Asthenia—Gliclazide—type 2 diabetes mellitus	0.000133	0.000892	CcSEcCtD
Rifabutin—Paraesthesia—Irbesartan—type 2 diabetes mellitus	0.000132	0.000882	CcSEcCtD
Rifabutin—Anorexia—Losartan—type 2 diabetes mellitus	0.000131	0.000881	CcSEcCtD
Rifabutin—Vomiting—Glyburide—type 2 diabetes mellitus	0.000131	0.000881	CcSEcCtD
Rifabutin—Pruritus—Gliclazide—type 2 diabetes mellitus	0.000131	0.00088	CcSEcCtD
Rifabutin—Dyspnoea—Irbesartan—type 2 diabetes mellitus	0.000131	0.000875	CcSEcCtD
Rifabutin—Rash—Glyburide—type 2 diabetes mellitus	0.00013	0.000873	CcSEcCtD
Rifabutin—Dermatitis—Glyburide—type 2 diabetes mellitus	0.00013	0.000872	CcSEcCtD
Rifabutin—Leukopenia—Ramipril—type 2 diabetes mellitus	0.00013	0.000869	CcSEcCtD
Rifabutin—Headache—Glyburide—type 2 diabetes mellitus	0.000129	0.000868	CcSEcCtD
Rifabutin—Dyspepsia—Irbesartan—type 2 diabetes mellitus	0.000129	0.000864	CcSEcCtD
Rifabutin—Feeling abnormal—Metformin—type 2 diabetes mellitus	0.000128	0.000857	CcSEcCtD
Rifabutin—Decreased appetite—Irbesartan—type 2 diabetes mellitus	0.000127	0.000854	CcSEcCtD
Rifabutin—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.000127	0.000851	CcSEcCtD
Rifabutin—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	0.000127	0.000851	CcSEcCtD
Rifabutin—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	0.000126	0.000848	CcSEcCtD
Rifabutin—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	0.000126	0.000842	CcSEcCtD
Rifabutin—Hypersensitivity—Valsartan—type 2 diabetes mellitus	0.000126	0.000842	CcSEcCtD
Rifabutin—Convulsion—Ramipril—type 2 diabetes mellitus	0.000126	0.000841	CcSEcCtD
Rifabutin—Pain—Irbesartan—type 2 diabetes mellitus	0.000125	0.00084	CcSEcCtD
Rifabutin—Insomnia—Losartan—type 2 diabetes mellitus	0.000125	0.000836	CcSEcCtD
Rifabutin—Hypersensitivity—Orlistat—type 2 diabetes mellitus	0.000124	0.000832	CcSEcCtD
Rifabutin—Paraesthesia—Losartan—type 2 diabetes mellitus	0.000124	0.00083	CcSEcCtD
Rifabutin—Chest pain—Ramipril—type 2 diabetes mellitus	0.000123	0.000827	CcSEcCtD
Rifabutin—Myalgia—Ramipril—type 2 diabetes mellitus	0.000123	0.000827	CcSEcCtD
Rifabutin—Arthralgia—Ramipril—type 2 diabetes mellitus	0.000123	0.000827	CcSEcCtD
Rifabutin—Dyspnoea—Losartan—type 2 diabetes mellitus	0.000123	0.000824	CcSEcCtD
Rifabutin—Nausea—Glyburide—type 2 diabetes mellitus	0.000123	0.000823	CcSEcCtD
Rifabutin—Abdominal pain—Metformin—type 2 diabetes mellitus	0.000123	0.000823	CcSEcCtD
Rifabutin—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	0.000122	0.000821	CcSEcCtD
Rifabutin—Asthenia—Valsartan—type 2 diabetes mellitus	0.000122	0.00082	CcSEcCtD
Rifabutin—Dyspepsia—Losartan—type 2 diabetes mellitus	0.000121	0.000813	CcSEcCtD
Rifabutin—Asthenia—Orlistat—type 2 diabetes mellitus	0.000121	0.00081	CcSEcCtD
Rifabutin—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	0.000121	0.000809	CcSEcCtD
Rifabutin—Pruritus—Valsartan—type 2 diabetes mellitus	0.000121	0.000808	CcSEcCtD
Rifabutin—Decreased appetite—Losartan—type 2 diabetes mellitus	0.00012	0.000803	CcSEcCtD
Rifabutin—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	0.00012	0.000803	CcSEcCtD
Rifabutin—Confusional state—Ramipril—type 2 diabetes mellitus	0.000119	0.000799	CcSEcCtD
Rifabutin—Pruritus—Orlistat—type 2 diabetes mellitus	0.000119	0.000799	CcSEcCtD
Rifabutin—Vomiting—Gliclazide—type 2 diabetes mellitus	0.000118	0.000791	CcSEcCtD
Rifabutin—Pain—Losartan—type 2 diabetes mellitus	0.000118	0.00079	CcSEcCtD
Rifabutin—Rash—Gliclazide—type 2 diabetes mellitus	0.000117	0.000784	CcSEcCtD
Rifabutin—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.000117	0.000783	CcSEcCtD
Rifabutin—Diarrhoea—Valsartan—type 2 diabetes mellitus	0.000117	0.000782	CcSEcCtD
Rifabutin—Shock—Ramipril—type 2 diabetes mellitus	0.000116	0.00078	CcSEcCtD
Rifabutin—Headache—Gliclazide—type 2 diabetes mellitus	0.000116	0.000779	CcSEcCtD
Rifabutin—Body temperature increased—Irbesartan—type 2 diabetes mellitus	0.000116	0.000776	CcSEcCtD
Rifabutin—Abdominal pain—Irbesartan—type 2 diabetes mellitus	0.000116	0.000776	CcSEcCtD
Rifabutin—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	0.000116	0.000776	CcSEcCtD
Rifabutin—Diarrhoea—Orlistat—type 2 diabetes mellitus	0.000115	0.000773	CcSEcCtD
Rifabutin—Skin disorder—Ramipril—type 2 diabetes mellitus	0.000115	0.00077	CcSEcCtD
Rifabutin—Feeling abnormal—Losartan—type 2 diabetes mellitus	0.000114	0.000762	CcSEcCtD
Rifabutin—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	0.000113	0.000756	CcSEcCtD
Rifabutin—Anorexia—Ramipril—type 2 diabetes mellitus	0.000113	0.000755	CcSEcCtD
Rifabutin—Asthenia—Metformin—type 2 diabetes mellitus	0.000111	0.000747	CcSEcCtD
Rifabutin—Nausea—Gliclazide—type 2 diabetes mellitus	0.00011	0.000739	CcSEcCtD
Rifabutin—Pruritus—Metformin—type 2 diabetes mellitus	0.00011	0.000736	CcSEcCtD
Rifabutin—Body temperature increased—Losartan—type 2 diabetes mellitus	0.000109	0.000731	CcSEcCtD
Rifabutin—Abdominal pain—Losartan—type 2 diabetes mellitus	0.000109	0.000731	CcSEcCtD
Rifabutin—Vomiting—Valsartan—type 2 diabetes mellitus	0.000108	0.000727	CcSEcCtD
Rifabutin—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	0.000108	0.000723	CcSEcCtD
Rifabutin—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	0.000108	0.000722	CcSEcCtD
Rifabutin—Rash—Valsartan—type 2 diabetes mellitus	0.000107	0.00072	CcSEcCtD
Rifabutin—Dermatitis—Valsartan—type 2 diabetes mellitus	0.000107	0.00072	CcSEcCtD
Rifabutin—Vomiting—Orlistat—type 2 diabetes mellitus	0.000107	0.000718	CcSEcCtD
Rifabutin—Insomnia—Ramipril—type 2 diabetes mellitus	0.000107	0.000717	CcSEcCtD
Rifabutin—Headache—Valsartan—type 2 diabetes mellitus	0.000107	0.000716	CcSEcCtD
Rifabutin—Diarrhoea—Metformin—type 2 diabetes mellitus	0.000106	0.000712	CcSEcCtD
Rifabutin—Rash—Orlistat—type 2 diabetes mellitus	0.000106	0.000712	CcSEcCtD
Rifabutin—Paraesthesia—Ramipril—type 2 diabetes mellitus	0.000106	0.000712	CcSEcCtD
Rifabutin—Dermatitis—Orlistat—type 2 diabetes mellitus	0.000106	0.000711	CcSEcCtD
Rifabutin—Headache—Orlistat—type 2 diabetes mellitus	0.000106	0.000707	CcSEcCtD
Rifabutin—Dyspnoea—Ramipril—type 2 diabetes mellitus	0.000105	0.000706	CcSEcCtD
Rifabutin—Asthenia—Irbesartan—type 2 diabetes mellitus	0.000105	0.000705	CcSEcCtD
Rifabutin—Dyspepsia—Ramipril—type 2 diabetes mellitus	0.000104	0.000698	CcSEcCtD
Rifabutin—Pruritus—Irbesartan—type 2 diabetes mellitus	0.000104	0.000695	CcSEcCtD
Rifabutin—Decreased appetite—Ramipril—type 2 diabetes mellitus	0.000103	0.000689	CcSEcCtD
Rifabutin—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	0.000102	0.000684	CcSEcCtD
Rifabutin—Hypersensitivity—Losartan—type 2 diabetes mellitus	0.000102	0.000681	CcSEcCtD
Rifabutin—Nausea—Valsartan—type 2 diabetes mellitus	0.000101	0.000679	CcSEcCtD
Rifabutin—Diarrhoea—Irbesartan—type 2 diabetes mellitus	0.0001	0.000672	CcSEcCtD
Rifabutin—Nausea—Orlistat—type 2 diabetes mellitus	0.0001	0.000671	CcSEcCtD
Rifabutin—Asthenia—Losartan—type 2 diabetes mellitus	9.89e-05	0.000663	CcSEcCtD
Rifabutin—Vomiting—Metformin—type 2 diabetes mellitus	9.87e-05	0.000662	CcSEcCtD
Rifabutin—Rash—Metformin—type 2 diabetes mellitus	9.79e-05	0.000656	CcSEcCtD
Rifabutin—Dermatitis—Metformin—type 2 diabetes mellitus	9.78e-05	0.000655	CcSEcCtD
Rifabutin—Pruritus—Losartan—type 2 diabetes mellitus	9.75e-05	0.000654	CcSEcCtD
Rifabutin—Feeling abnormal—Ramipril—type 2 diabetes mellitus	9.74e-05	0.000653	CcSEcCtD
Rifabutin—Headache—Metformin—type 2 diabetes mellitus	9.73e-05	0.000652	CcSEcCtD
Rifabutin—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	9.67e-05	0.000648	CcSEcCtD
Rifabutin—Diarrhoea—Losartan—type 2 diabetes mellitus	9.43e-05	0.000632	CcSEcCtD
Rifabutin—Body temperature increased—Ramipril—type 2 diabetes mellitus	9.35e-05	0.000626	CcSEcCtD
Rifabutin—Abdominal pain—Ramipril—type 2 diabetes mellitus	9.35e-05	0.000626	CcSEcCtD
Rifabutin—Vomiting—Irbesartan—type 2 diabetes mellitus	9.31e-05	0.000624	CcSEcCtD
Rifabutin—Rash—Irbesartan—type 2 diabetes mellitus	9.24e-05	0.000619	CcSEcCtD
Rifabutin—Dermatitis—Irbesartan—type 2 diabetes mellitus	9.23e-05	0.000619	CcSEcCtD
Rifabutin—Nausea—Metformin—type 2 diabetes mellitus	9.22e-05	0.000618	CcSEcCtD
Rifabutin—Headache—Irbesartan—type 2 diabetes mellitus	9.18e-05	0.000615	CcSEcCtD
Rifabutin—Vomiting—Losartan—type 2 diabetes mellitus	8.77e-05	0.000588	CcSEcCtD
Rifabutin—Hypersensitivity—Ramipril—type 2 diabetes mellitus	8.71e-05	0.000584	CcSEcCtD
Rifabutin—Nausea—Irbesartan—type 2 diabetes mellitus	8.7e-05	0.000583	CcSEcCtD
Rifabutin—Rash—Losartan—type 2 diabetes mellitus	8.69e-05	0.000583	CcSEcCtD
Rifabutin—Dermatitis—Losartan—type 2 diabetes mellitus	8.69e-05	0.000582	CcSEcCtD
Rifabutin—Headache—Losartan—type 2 diabetes mellitus	8.64e-05	0.000579	CcSEcCtD
Rifabutin—Asthenia—Ramipril—type 2 diabetes mellitus	8.48e-05	0.000569	CcSEcCtD
Rifabutin—Pruritus—Ramipril—type 2 diabetes mellitus	8.36e-05	0.000561	CcSEcCtD
Rifabutin—Nausea—Losartan—type 2 diabetes mellitus	8.19e-05	0.000549	CcSEcCtD
Rifabutin—Diarrhoea—Ramipril—type 2 diabetes mellitus	8.09e-05	0.000542	CcSEcCtD
Rifabutin—Vomiting—Ramipril—type 2 diabetes mellitus	7.52e-05	0.000504	CcSEcCtD
Rifabutin—Rash—Ramipril—type 2 diabetes mellitus	7.45e-05	0.0005	CcSEcCtD
Rifabutin—Dermatitis—Ramipril—type 2 diabetes mellitus	7.45e-05	0.000499	CcSEcCtD
Rifabutin—Headache—Ramipril—type 2 diabetes mellitus	7.41e-05	0.000496	CcSEcCtD
Rifabutin—Nausea—Ramipril—type 2 diabetes mellitus	7.02e-05	0.000471	CcSEcCtD
Rifabutin—HSP90AA1—Metabolism—PPARA—type 2 diabetes mellitus	1.5e-05	0.000128	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—APOB—type 2 diabetes mellitus	1.49e-05	0.000127	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—IGF1R—type 2 diabetes mellitus	1.48e-05	0.000126	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—EDN1—type 2 diabetes mellitus	1.46e-05	0.000125	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—AGT—type 2 diabetes mellitus	1.45e-05	0.000124	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—INS—type 2 diabetes mellitus	1.45e-05	0.000124	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—CALM1—type 2 diabetes mellitus	1.43e-05	0.000122	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—APOE—type 2 diabetes mellitus	1.42e-05	0.000121	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—LPL—type 2 diabetes mellitus	1.42e-05	0.000121	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—AANAT—type 2 diabetes mellitus	1.42e-05	0.000121	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—PTGDS—type 2 diabetes mellitus	1.42e-05	0.000121	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—APOA1—type 2 diabetes mellitus	1.41e-05	0.00012	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—AKT2—type 2 diabetes mellitus	1.4e-05	0.00012	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—ADCY5—type 2 diabetes mellitus	1.39e-05	0.000119	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—PIK3R1—type 2 diabetes mellitus	1.38e-05	0.000118	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—CPT1A—type 2 diabetes mellitus	1.35e-05	0.000115	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—CDO1—type 2 diabetes mellitus	1.35e-05	0.000115	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—GPD2—type 2 diabetes mellitus	1.35e-05	0.000115	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—IL6—type 2 diabetes mellitus	1.34e-05	0.000114	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—SERPINE1—type 2 diabetes mellitus	1.33e-05	0.000114	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	1.33e-05	0.000114	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—BCL2—type 2 diabetes mellitus	1.33e-05	0.000113	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—LIPC—type 2 diabetes mellitus	1.32e-05	0.000112	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—CCR5—type 2 diabetes mellitus	1.31e-05	0.000112	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—CYP11A1—type 2 diabetes mellitus	1.31e-05	0.000111	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—RELA—type 2 diabetes mellitus	1.3e-05	0.000111	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—AK1—type 2 diabetes mellitus	1.28e-05	0.000109	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—C3—type 2 diabetes mellitus	1.28e-05	0.000109	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—PIK3R1—type 2 diabetes mellitus	1.27e-05	0.000109	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—NOS3—type 2 diabetes mellitus	1.27e-05	0.000109	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—CETP—type 2 diabetes mellitus	1.27e-05	0.000108	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—BHMT—type 2 diabetes mellitus	1.25e-05	0.000107	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—PPARG—type 2 diabetes mellitus	1.24e-05	0.000106	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—AKT1—type 2 diabetes mellitus	1.23e-05	0.000105	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—HIF1A—type 2 diabetes mellitus	1.22e-05	0.000104	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—IRS2—type 2 diabetes mellitus	1.22e-05	0.000104	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—INS—type 2 diabetes mellitus	1.22e-05	0.000104	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—AGT—type 2 diabetes mellitus	1.22e-05	0.000104	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—CALM1—type 2 diabetes mellitus	1.2e-05	0.000102	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—LEP—type 2 diabetes mellitus	1.19e-05	0.000102	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—APOE—type 2 diabetes mellitus	1.19e-05	0.000102	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—MAT1A—type 2 diabetes mellitus	1.18e-05	0.000101	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—SLC5A4—type 2 diabetes mellitus	1.18e-05	0.000101	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—IL6—type 2 diabetes mellitus	1.18e-05	0.000101	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—SREBF1—type 2 diabetes mellitus	1.18e-05	0.000101	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—APOA1—type 2 diabetes mellitus	1.18e-05	0.0001	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—PTGS2—type 2 diabetes mellitus	1.17e-05	9.93e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—type 2 diabetes mellitus	1.16e-05	9.87e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—HMGCR—type 2 diabetes mellitus	1.15e-05	9.78e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—ENPP1—type 2 diabetes mellitus	1.14e-05	9.75e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—ND1—type 2 diabetes mellitus	1.14e-05	9.75e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—PPP1R3C—type 2 diabetes mellitus	1.14e-05	9.75e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—HBA2—type 2 diabetes mellitus	1.14e-05	9.75e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—G6PC—type 2 diabetes mellitus	1.14e-05	9.75e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—PRKCB—type 2 diabetes mellitus	1.12e-05	9.57e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—ALB—type 2 diabetes mellitus	1.12e-05	9.51e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—GCGR—type 2 diabetes mellitus	1.11e-05	9.45e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—NFKB1—type 2 diabetes mellitus	1.1e-05	9.34e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—PTGDS—type 2 diabetes mellitus	1.1e-05	9.34e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—AANAT—type 2 diabetes mellitus	1.1e-05	9.34e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—AKT1—type 2 diabetes mellitus	1.09e-05	9.28e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—PIK3R1—type 2 diabetes mellitus	1.07e-05	9.1e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—NOS3—type 2 diabetes mellitus	1.07e-05	9.1e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—IRS1—type 2 diabetes mellitus	1.06e-05	9.06e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—CYTB—type 2 diabetes mellitus	1.05e-05	8.92e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—OXCT1—type 2 diabetes mellitus	1.05e-05	8.92e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—CDO1—type 2 diabetes mellitus	1.04e-05	8.85e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—GPD2—type 2 diabetes mellitus	1.04e-05	8.85e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—SRC—type 2 diabetes mellitus	1.02e-05	8.7e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—SRD5A1—type 2 diabetes mellitus	1.02e-05	8.69e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—INS—type 2 diabetes mellitus	1.02e-05	8.67e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—CCL2—type 2 diabetes mellitus	1e-05	8.53e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—AK1—type 2 diabetes mellitus	9.91e-06	8.44e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—IGF1—type 2 diabetes mellitus	9.84e-06	8.39e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—AKT2—type 2 diabetes mellitus	9.84e-06	8.38e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—PTGS2—type 2 diabetes mellitus	9.76e-06	8.32e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—STAR—type 2 diabetes mellitus	9.73e-06	8.29e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—HSD17B3—type 2 diabetes mellitus	9.73e-06	8.29e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—ACACA—type 2 diabetes mellitus	9.73e-06	8.29e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—SRC—type 2 diabetes mellitus	9.43e-06	8.03e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	9.35e-06	7.97e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—ABCC8—type 2 diabetes mellitus	9.33e-06	7.95e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—CBS—type 2 diabetes mellitus	9.33e-06	7.95e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—SLC5A4—type 2 diabetes mellitus	9.14e-06	7.79e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—MAT1A—type 2 diabetes mellitus	9.14e-06	7.79e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—COX2—type 2 diabetes mellitus	8.98e-06	7.65e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—SLC5A2—type 2 diabetes mellitus	8.98e-06	7.65e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—EGFR—type 2 diabetes mellitus	8.95e-06	7.63e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	8.92e-06	7.61e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—NOS3—type 2 diabetes mellitus	8.92e-06	7.61e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—ENPP1—type 2 diabetes mellitus	8.83e-06	7.53e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—G6PC—type 2 diabetes mellitus	8.83e-06	7.53e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—ND1—type 2 diabetes mellitus	8.83e-06	7.53e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—HBA2—type 2 diabetes mellitus	8.83e-06	7.53e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—PPP1R3C—type 2 diabetes mellitus	8.83e-06	7.53e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—NCOA6—type 2 diabetes mellitus	8.82e-06	7.52e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—PPARGC1A—type 2 diabetes mellitus	8.82e-06	7.51e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—HSD11B1—type 2 diabetes mellitus	8.67e-06	7.39e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—UCP2—type 2 diabetes mellitus	8.67e-06	7.39e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—UCP3—type 2 diabetes mellitus	8.67e-06	7.39e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—GCGR—type 2 diabetes mellitus	8.55e-06	7.29e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—TGFB1—type 2 diabetes mellitus	8.43e-06	7.18e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—APOB—type 2 diabetes mellitus	8.41e-06	7.16e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—RELA—type 2 diabetes mellitus	8.4e-06	7.16e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—EGFR—type 2 diabetes mellitus	8.26e-06	7.04e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—PCK1—type 2 diabetes mellitus	8.15e-06	6.95e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—CYTB—type 2 diabetes mellitus	8.08e-06	6.88e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—OXCT1—type 2 diabetes mellitus	8.08e-06	6.88e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—LPL—type 2 diabetes mellitus	8.03e-06	6.84e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—SRD5A1—type 2 diabetes mellitus	7.87e-06	6.71e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—type 2 diabetes mellitus	7.83e-06	6.67e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—HK1—type 2 diabetes mellitus	7.64e-06	6.51e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—CD36—type 2 diabetes mellitus	7.63e-06	6.5e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—CASP3—type 2 diabetes mellitus	7.58e-06	6.46e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—ACACA—type 2 diabetes mellitus	7.51e-06	6.4e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—STAR—type 2 diabetes mellitus	7.51e-06	6.4e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—HSD17B3—type 2 diabetes mellitus	7.51e-06	6.4e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—LPA—type 2 diabetes mellitus	7.37e-06	6.28e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—GCKR—type 2 diabetes mellitus	7.37e-06	6.28e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—HSD3B2—type 2 diabetes mellitus	7.37e-06	6.28e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—KCNJ11—type 2 diabetes mellitus	7.37e-06	6.28e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—ABCC8—type 2 diabetes mellitus	7.2e-06	6.14e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—CBS—type 2 diabetes mellitus	7.2e-06	6.14e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—MMP9—type 2 diabetes mellitus	7.16e-06	6.1e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	7.09e-06	6.04e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	7.08e-06	6.04e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—ALDOB—type 2 diabetes mellitus	7.07e-06	6.03e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—COX2—type 2 diabetes mellitus	6.93e-06	5.91e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—SLC5A2—type 2 diabetes mellitus	6.93e-06	5.91e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—IL6—type 2 diabetes mellitus	6.88e-06	5.86e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	6.87e-06	5.85e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—NCOA6—type 2 diabetes mellitus	6.81e-06	5.8e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	6.73e-06	5.73e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—UCP3—type 2 diabetes mellitus	6.69e-06	5.7e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—UCP2—type 2 diabetes mellitus	6.69e-06	5.7e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—HSD11B1—type 2 diabetes mellitus	6.69e-06	5.7e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	6.65e-06	5.67e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—SRC—type 2 diabetes mellitus	6.6e-06	5.63e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—GLP1R—type 2 diabetes mellitus	6.57e-06	5.6e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	6.43e-06	5.48e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—IL6—type 2 diabetes mellitus	6.35e-06	5.41e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—AKT1—type 2 diabetes mellitus	6.35e-06	5.41e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—PCK1—type 2 diabetes mellitus	6.29e-06	5.36e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—SLC2A2—type 2 diabetes mellitus	6.14e-06	5.23e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—MTR—type 2 diabetes mellitus	6.01e-06	5.12e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—CPT1A—type 2 diabetes mellitus	6.01e-06	5.12e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	5.9e-06	5.03e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—NAMPT—type 2 diabetes mellitus	5.9e-06	5.02e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—HK1—type 2 diabetes mellitus	5.89e-06	5.02e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	5.86e-06	4.99e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—AKT1—type 2 diabetes mellitus	5.86e-06	4.99e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—HBA1—type 2 diabetes mellitus	5.86e-06	4.99e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—LIPC—type 2 diabetes mellitus	5.86e-06	4.99e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—GCK—type 2 diabetes mellitus	5.86e-06	4.99e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—CYP11A1—type 2 diabetes mellitus	5.82e-06	4.96e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—EGFR—type 2 diabetes mellitus	5.79e-06	4.93e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—SLC9A1—type 2 diabetes mellitus	5.72e-06	4.87e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—GCKR—type 2 diabetes mellitus	5.69e-06	4.85e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—LPA—type 2 diabetes mellitus	5.69e-06	4.85e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—KCNJ11—type 2 diabetes mellitus	5.69e-06	4.85e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—HSD3B2—type 2 diabetes mellitus	5.69e-06	4.85e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—CETP—type 2 diabetes mellitus	5.65e-06	4.82e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—ALDOB—type 2 diabetes mellitus	5.46e-06	4.65e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	5.27e-06	4.49e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—PSMD6—type 2 diabetes mellitus	5.25e-06	4.48e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—SNAP25—type 2 diabetes mellitus	5.25e-06	4.48e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—SREBF1—type 2 diabetes mellitus	5.25e-06	4.48e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—CTGF—type 2 diabetes mellitus	5.16e-06	4.4e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—HMGCR—type 2 diabetes mellitus	5.11e-06	4.36e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	5.07e-06	4.32e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	5.04e-06	4.3e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—ADRA2A—type 2 diabetes mellitus	5e-06	4.26e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—AKT1—type 2 diabetes mellitus	4.91e-06	4.18e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—CYP2E1—type 2 diabetes mellitus	4.81e-06	4.1e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—SLC2A1—type 2 diabetes mellitus	4.75e-06	4.05e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	4.74e-06	4.04e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	4.64e-06	3.95e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	4.64e-06	3.95e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—CYP3A4—type 2 diabetes mellitus	4.63e-06	3.95e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	4.61e-06	3.93e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—SLC2A4—type 2 diabetes mellitus	4.56e-06	3.88e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—GCG—type 2 diabetes mellitus	4.56e-06	3.88e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	4.55e-06	3.88e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	4.52e-06	3.85e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	4.52e-06	3.85e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	4.52e-06	3.85e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	4.49e-06	3.83e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—IL6—type 2 diabetes mellitus	4.45e-06	3.79e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	4.41e-06	3.76e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	4.36e-06	3.72e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—AKT1—type 2 diabetes mellitus	4.1e-06	3.5e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	4.06e-06	3.46e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	4.06e-06	3.46e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	4.06e-06	3.46e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	3.98e-06	3.39e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	3.94e-06	3.36e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—GNB3—type 2 diabetes mellitus	3.93e-06	3.35e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.93e-06	3.35e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—HMOX1—type 2 diabetes mellitus	3.91e-06	3.33e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	3.86e-06	3.29e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—CAT—type 2 diabetes mellitus	3.86e-06	3.29e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—APOB—type 2 diabetes mellitus	3.74e-06	3.19e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	3.71e-06	3.16e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	3.67e-06	3.13e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	3.67e-06	3.13e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—GSTM1—type 2 diabetes mellitus	3.64e-06	3.1e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—LPL—type 2 diabetes mellitus	3.58e-06	3.05e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	3.52e-06	3e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	3.52e-06	3e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—ADCY5—type 2 diabetes mellitus	3.5e-06	2.98e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—GPX1—type 2 diabetes mellitus	3.49e-06	2.97e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—CD36—type 2 diabetes mellitus	3.4e-06	2.89e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—PPP2CA—type 2 diabetes mellitus	3.35e-06	2.86e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—MTHFR—type 2 diabetes mellitus	3.22e-06	2.74e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—PPARA—type 2 diabetes mellitus	3.16e-06	2.69e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—AGT—type 2 diabetes mellitus	3.06e-06	2.61e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	3.03e-06	2.58e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.03e-06	2.58e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	3.02e-06	2.57e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—CALM1—type 2 diabetes mellitus	3.01e-06	2.56e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—APOE—type 2 diabetes mellitus	3e-06	2.55e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	2.98e-06	2.54e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—APOA1—type 2 diabetes mellitus	2.96e-06	2.52e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	2.89e-06	2.46e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	2.81e-06	2.4e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	2.76e-06	2.35e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	2.7e-06	2.3e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	2.69e-06	2.29e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	2.62e-06	2.23e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—PPARG—type 2 diabetes mellitus	2.61e-06	2.22e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	2.59e-06	2.21e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—INS—type 2 diabetes mellitus	2.56e-06	2.18e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	2.48e-06	2.12e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	2.44e-06	2.08e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	2.36e-06	2.01e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—ALB—type 2 diabetes mellitus	2.35e-06	2e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	2.32e-06	1.98e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	2.31e-06	1.97e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	2.29e-06	1.95e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—PIK3R1—type 2 diabetes mellitus	2.25e-06	1.91e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—NOS3—type 2 diabetes mellitus	2.25e-06	1.91e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—PTGS2—type 2 diabetes mellitus	2.05e-06	1.75e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	2.01e-06	1.72e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	1.98e-06	1.68e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	1.81e-06	1.54e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	1.73e-06	1.48e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	1.73e-06	1.48e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	1.58e-06	1.35e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—AKT1—type 2 diabetes mellitus	1.03e-06	8.79e-06	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	7.96e-07	6.79e-06	CbGpPWpGaD
